和邦生物 (603077.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(和邦生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 6,434,462,278.944,090,613,303.822,394,468,174.8413,038,947,986.8010,493,324,771.697,479,029,894.833,086,136,455.48
 营业收入(元) 6,434,462,278.944,090,613,303.822,394,468,174.8413,038,947,986.8010,493,324,771.697,479,029,894.833,086,136,455.48
二、营业总成本(元) 5,261,021,840.033,368,929,779.361,917,401,447.528,554,850,137.626,504,257,983.264,373,969,994.971,850,614,881.23
 营业成本(元) 4,886,566,967.783,124,929,665.761,769,492,414.837,451,315,369.965,700,298,235.103,862,080,126.561,616,810,468.35
 研发费用(元) 28,642,997.8018,108,486.149,108,322.9367,933,955.5024,448,451.0116,948,563.957,666,274.21
 营业税金及附加(元) 43,381,215.6929,132,743.1413,891,280.65114,023,647.7793,395,296.5268,956,980.4022,867,886.64
 销售费用(元) 41,065,821.4127,286,146.3013,859,454.2452,482,761.3737,423,635.9820,913,851.9511,995,668.84
 管理费用(元) 268,460,823.50173,500,785.00106,161,061.05844,968,748.93622,691,639.93388,348,388.37183,452,506.13
 财务费用(元) -7,095,986.15-4,028,046.984,888,913.8224,125,654.0926,000,724.7216,722,083.747,822,077.06
  其中:利息费用(元) 42,074,390.0827,129,521.3614,275,437.5251,434,560.1745,957,744.8130,339,718.6014,857,938.51
  其中:利息收入(元) 43,564,152.4227,703,996.4910,789,441.2522,688,634.5815,068,747.188,051,521.923,623,533.93
三、其他经营收益
 加:投资收益(元) 46,105,613.6742,385,477.436,412,117.1521,831,129.2117,333,296.8712,899,930.863,536,799.42
  其中:对联营企业和合营企业的投资收益(元) 45,317,746.4039,907,918.513,884,758.1519,669,573.0117,972,345.4113,324,375.985,180,587.76
 资产处置收益(元) 889,135.774,489.843,091.7737,102,614.1636,987,545.67-179,656.47-9,646.65
 资产减值损失(元) --28,382,477.82--80,828,247.69---
 信用减值损失(元) -21,622,648.41-11,584,012.79-9,040,151.94-12,756,078.84-20,067,354.25-26,915,208.22-20,251,493.43
 其他收益(元) 11,790,148.535,442,280.072,764,429.7431,709,915.5418,174,541.5215,200,014.9611,275,777.77
四、营业利润(元) 1,210,602,688.47729,549,281.19477,206,214.044,481,157,181.564,041,494,818.243,106,064,980.991,230,073,011.36
 加:营业外收入(元) 41.7434.889.2458,363.7214,101.1512,881.812,253.63
 减:营业外支出(元) 763,880.83713,463.72622,403.932,653,401.702,493,977.742,467,335.282,446,054.02
五、利润总额(元) 1,209,838,849.38728,835,852.35476,583,819.354,478,562,143.584,039,014,941.653,103,610,527.521,227,629,210.97
 减:所得税费用(元) 195,763,416.26125,693,957.2495,123,195.45668,323,208.83604,646,950.23462,856,119.21182,502,911.84
六、净利润(元) 1,014,075,433.12603,141,895.11381,460,623.903,810,238,934.753,434,367,991.422,640,754,408.311,045,126,299.13
(一)按经营持续性分类
  持续经营净利润(元) 1,014,075,433.12603,141,895.11381,460,623.903,810,238,934.753,434,367,991.422,640,754,408.311,045,126,299.13
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 1,019,044,364.44616,531,723.76396,561,190.753,806,808,869.243,427,501,728.442,634,634,940.011,042,725,403.09
  少数股东损益(元) -4,968,931.32-13,389,828.65-15,100,566.853,430,065.516,866,262.986,119,468.302,400,896.04
 扣除非经常性损益后的净利润(元) 990,505,525.22592,884,490.66396,418,118.883,751,475,244.683,382,663,344.112,627,548,416.441,036,942,438.83
七、每股收益
 一、基本每股收益(元) 0.120.070.050.440.390.300.12
 二、稀释每股收益(元) 0.120.070.050.440.390.300.12
八、其他综合收益(元) -61,744.1814,074,680.68-11,232,306.6243,261,731.8453,145,606.7825,282,061.44647,492.95
 归属于母公司股东的其他综合收益(元) -5,852,663.377,380,745.67-9,740,716.8031,335,739.5039,338,424.6318,932,705.06918,984.54
 归属于少数股东的其他综合收益(元) 5,790,919.196,693,935.01-1,491,589.8211,925,992.3413,807,182.156,349,356.38-271,491.59
九、综合收益总额(元) 1,014,013,688.94617,216,575.79370,228,317.283,853,500,666.593,487,513,598.202,666,036,469.751,045,773,792.08
 归属于母公司所有者的综合收益总额(元) 1,013,191,701.07623,912,469.43386,820,473.953,838,144,608.743,466,840,153.072,653,567,645.071,043,644,387.63
 归属于少数股东的综合收益总额(元) 821,987.87-6,695,893.64-16,592,156.6715,356,057.8520,673,445.1312,468,824.682,129,404.45
公告日期 2023-10-212023-08-302023-04-292023-02-212022-10-282022-07-292022-04-26
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院